These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3577882)

  • 1. [Deep tumors of the bladder. Radical treatment. Analysis of survival factors].
    Zudaire Bergera JJ; Robles García JE; Vallejo Benalcazar S; Ucar Terren A; Ponz González M; Berián Polo JM
    Actas Urol Esp; 1987; 11(1):15-22. PubMed ID: 3577882
    [No Abstract]   [Full Text] [Related]  

  • 2. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
    Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
    J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bladder conservation treatment in the elderly population: results and prognostic factors of muscle-invasive bladder cancer.
    Tran E; Souhami L; Tanguay S; Rajan R
    Am J Clin Oncol; 2009 Aug; 32(4):333-7. PubMed ID: 19381080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
    Boudreaux KJ; Clark PE; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Chang SS
    J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Consideration of therapeutic choice for grade 3 superficial bladder cancer].
    Noguchi S; Kubota Y; Takase K; Masuda M; Yao M; Hosaka M; Miura T; Kondoh I; Kawasaki C; Moriyama M
    Hinyokika Kiyo; 1996 Sep; 42(9):635-8. PubMed ID: 8918660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [5-year results of a chemo-immunotherapeutic treatment in stage-I and -II malignant melanoma].
    Comella G; Mastro AA; Comella P; Castello G; De Simone G; Cerra R; Zarrilli D
    Minerva Med; 1986 Mar; 77(13):507-10. PubMed ID: 3703343
    [No Abstract]   [Full Text] [Related]  

  • 8. Small cell carcinoma of the urinary bladder. The Mayo Clinic experience.
    Choong NW; Quevedo JF; Kaur JS
    Cancer; 2005 Mar; 103(6):1172-8. PubMed ID: 15700264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in superficial bladder cancer.
    Aso Y; Anderson L; Soloway M; Bouffioux C; Chisholm G; Debruyne F; Kawai T; Kurth KH; Maru A; Straffon WG
    Prog Clin Biol Res; 1986; 221():257-69. PubMed ID: 3809183
    [No Abstract]   [Full Text] [Related]  

  • 10. [Influence of neoadjuvant treatment on bladder infiltrating tumors treated with radical cystectomy].
    Martín-Marquina Aspiunza A; Zudaire Bergera JJ; Arocena García-Tapia J; Sanz Pérez G; Díaz-Caballero Alonso F; Rodríguez-Rubio Cortadellas F; Rosell Costa D; Robles García JE; Berián Polo JM
    Actas Urol Esp; 1998 Sep; 22(8):650-4. PubMed ID: 9835083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
    Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
    J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment outcome and prognostic variables for local control and survival in patients receiving radical radiotherapy for urinary bladder cancer.
    Fokdal L; Høyer M; von der Maase H
    Acta Oncol; 2004; 43(8):749-57. PubMed ID: 15764221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of malpractice caps on use and outcomes of radical cystectomy for bladder cancer: data from the surveillance, epidemiology, and end results program.
    Konety BR; Dhawan V; Allareddy V; Joslyn SA
    J Urol; 2005 Jun; 173(6):2085-9. PubMed ID: 15879848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study of squamous cell carcinoma of the bladder].
    Kagawa S; Maebayashi K; Saiki T; Kawano A; Kurokawa K
    Hinyokika Kiyo; 1984 Apr; 30(4):467-9. PubMed ID: 6485958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Infiltrating bladder carcinoma: influence of complementary treatment on local control and survival].
    Berián Polo JM; Zudaire Bergera JJ; Robles García JE; de Castro Barbosa F
    Actas Urol Esp; 1994 May; 18 Suppl():520-6. PubMed ID: 8073942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radical treatment of invasive bladder cancer].
    Lopatkin NA; Darenkov SP; Chernyshev NV; Sokolov AE; Gorilovskiĭ ML; Akmatov NA; Samsonov IuV
    Urologiia; 2003; (4):3-8. PubMed ID: 12942717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term prognosis of bladder cancer. Evaluation with urinary CEA.
    Holmberg V; Nilsson B
    Anticancer Res; 1984; 4(3):121-2. PubMed ID: 6465848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similar treatment outcomes for radical cystectomy and radical radiotherapy in invasive bladder cancer treated at a United Kingdom specialist treatment center.
    Kotwal S; Choudhury A; Johnston C; Paul AB; Whelan P; Kiltie AE
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):456-63. PubMed ID: 17904301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing aggressive therapy for bladder cancer: an analysis of data from the SEER program.
    Konety BR; Joslyn SA
    J Urol; 2003 Nov; 170(5):1765-71. PubMed ID: 14532772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy of invasive bladder cancer.
    Dinney CP
    Urology; 2006 Mar; 67(3 Suppl 1):56-9; discussion 60-1. PubMed ID: 16530078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.